Amato Giaccia
Fondateur chez Arresto BioSciences, Inc.
Fortune : 150 492 $ au 31/12/2023
Profil
Amato J.
Giaccia is the founder of Proacta, Inc. (founded in 2001), Arresto BioSciences, Inc. (founded in 2007), and Aravive Biologics, Inc. (founded in 2010).
He held the title of Director & Chief Scientific Officer at Aravive Biologics, Inc. from 2017 to 2018.
Dr. Giaccia is also the founder of AKSO Biopharmaceutical, Inc. Dr. Giaccia's current job(s) include being the Associate Director-Basic Science at Stanford Cancer Institute and a Professor at Stanford University School of Medicine.
Dr. Giaccia's former job(s) include being the Director at Oxford Institute for Energy Studies and Versartis, Inc. He also served as an Independent Director at Aravive, Inc. from 2018 to 2024.
Dr. Giaccia obtained a doctorate degree from the University of Pennsylvania.
Dr. Giaccia is also the founder of AKSO Biopharmaceutical, Inc...
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARAVIVE, INC.
1,65% | 03/08/2023 | 1 213 648 ( 1,65% ) | 150 492 $ | 31/12/2023 |
Postes actifs de Amato Giaccia
| Sociétés | Poste | Début |
|---|---|---|
Arresto BioSciences, Inc.
 Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | Fondateur | 14/08/2009 |
| Stanford Cancer Institute | Corporate Officer/Principal | - |
| Stanford University School of Medicine | Corporate Officer/Principal | - |
| AKSO Biopharmaceutical, Inc. | Fondateur | - |
Anciens postes connus de Amato Giaccia
| Sociétés | Poste | Fin |
|---|---|---|
| ARAVIVE, INC. | Directeur/Membre du Conseil | 17/01/2024 |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Fondateur | 12/10/2018 |
Oxford Institute for Energy Studies
 Oxford Institute for Energy Studies Miscellaneous Commercial ServicesCommercial Services Oxford Institute for Energy Studies operates as an energy research institute. Its three main programs include oil, natural gas, and electricity. It publishes analysis of topical global energy issues across production, consumption, markets, policy and regulation. The company is headquartered in Oxford, the United Kingdom. | Directeur/Membre du Conseil | - |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Directeur/Membre du Conseil | - |
Proacta, Inc.
 Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Fondateur | - |
Formation de Amato Giaccia
| University of Pennsylvania | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARAVIVE, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Proacta, Inc.
Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Health Technology |
Oxford Institute for Energy Studies
Oxford Institute for Energy Studies Miscellaneous Commercial ServicesCommercial Services Oxford Institute for Energy Studies operates as an energy research institute. Its three main programs include oil, natural gas, and electricity. It publishes analysis of topical global energy issues across production, consumption, markets, policy and regulation. The company is headquartered in Oxford, the United Kingdom. | Commercial Services |
Arresto BioSciences, Inc.
Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | Commercial Services |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
| Stanford Cancer Institute | |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Health Technology |
| AKSO Biopharmaceutical, Inc. |
